Applied BioCode (6598.TW) Earnings Analysis

Applied BioCode (6598.TW) next reports earnings on 2026-08-20. Last quarter (2026-03-11) it missed with EPS -0.63 TWD vs -0.48 TWD est (-31.3%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -19.96.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6598.TW next report earnings?

Next earnings date2026-08-20
Consensus EPS estimaten/a
Revenue estimaten/a

6598.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-11-0.63 TWD-0.48 TWD-31.3%Miss
2025-11-06-0.33 TWD-0.43 TWD+23.3%Beat
2025-05-08-0.35 TWDn/an/an/a
2025-03-13-0.78 TWD-0.32131 TWD-142.8%Miss
2024-11-11-0.8 TWD-0.41581 TWD-92.4%Miss
2024-08-22-0.61 TWD-0.51 TWD-19.6%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

6598.TW valuation and analyst view

Trailing P/E-19.96
Trailing EPS-1.37744 TWD
Price / book4.40
Dividend yield0.00%
Market cap2.86B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Applied BioCode (6598.TW)'s next earnings date?

Applied BioCode is next scheduled to report on 2026-08-20.

Did 6598.TW beat earnings last quarter?

In its 2026-03-11 report, 6598.TW posted EPS of -0.63 TWD versus a -0.48 TWD estimate — a miss of 31.3%.

What is 6598.TW's earnings track record?

Over the last 5 reported quarters with consensus data, 6598.TW beat estimates 1 times (20%).

What is 6598.TW's current P/E ratio and EPS?

6598.TW trades at a trailing P/E of -19.96 on trailing EPS of -1.3774441107774442 TWD.

What do analysts rate 6598.TW?

6598.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.